JonathanCharlesRobertsMD
Hematology • Peoria, ILClotting Disorder
Associate Medical Director and Research Director, Bleeding & Clotting Disorders Institute, Peoria, IL Assistant Professor of Pediatrics and Medicine, University of IL College of Medicine at Peoria, Peoria, IL
Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
427 W Northmoor Rd
Bleeding & Clotting Disorders Institute
Peoria, IL 61614Phone+1 309-692-5337Fax+1 309-693-3913
Summary
- Associate Medical & Research Director - Bleeding & Clotting Disorders Institute, Peoria, IL
Assistant Professor of Pediatrics - University of Illinois College of Medicine at Peoria, Peoria, IL
Specializing in Hemophilia, von Willebrand Disease, management of other bleeding disorders, and thrombosis, as well as other benign hematologic conditions
Board Certified General Pediatrics
Board Certified Pediatric Hematology/Oncology
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Pediatric Hematology/Oncology, 2011 - 2014
University of Illinois College of Medicine at PeoriaResidency, Pediatrics, 2008 - 2011
Southern Illinois University School of MedicineClass of 2008
Greenville CollegeB.A., Chemistry and Biology, Summa Cum Laude, 2000 - 2004
Certifications & Licensure
IL State Medical License 2008 - 2026
WI State Medical License 2011 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Young Investigator Award, highest rated abstract and selection for oral presentation International Society on Thrombosis & Haemostasis, 2016
- Volunteer Faculty Distinguished Teacher Award, Internal Medicine Residency Program University of Illinois College of Medicine at Peoria, 2015
- Young Investigator Award, Tie for 2nd Highest Rated Abstract International Society on Thrombosis & Haemostasis, 2014
- Join now to see all
Clinical Trials
- Von Willebrand Factor in Pregnancy (VIP) Study Start of enrollment: 2019 Oct 12
Roles: Contact, Principal Investigator
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) Start of enrollment: 2017 Dec 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- 55 citationsRecombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.Michael D. Tarantino, Adam Cuker, Brandon M. Hardesty, Jonathan C. Roberts, Michelle Sholzberg
Haemophilia. 2017-01-01 - 50 citationsSevere, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 VaccineJackie M Helms, Kristin T Ansteatt, Jonathan C. Roberts, Sravani Kamatam, Kap Sum Foong
Journal of Blood Medicine. 2021-04-06 - 20 citationsRapid discrimination of the phenotypic variants of von Willebrand diseaseJonathan C. Roberts, Patti A Morateck, Pamela A. Christopherson, Ke Yan, Raymond G. Hoffmann
Blood. 2016-05-19
Journal Articles
- An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in IllinoisAnnia Martial, Michael D Tarantino, Jonathan C Roberts, Amar H Kelkar, Harsha Moole, The New England Journal of Medicine
Abstracts/Posters
- Feasibility and Content Validity of Goal Attainment Scaling for Hemophilia (GAS-Hem): a Novel Personalized Approach to Measuring Progress in Patients with Hemophilia.Roberts JC, Rockwood K, Recht M, Lattimore S, Gue D, Denne MB, Robinson KS, Price V, Squie S, Haemophilia, 1/1/2017
- Characterization of Laboratory Coagulation Parameters and Risk Factors for Intraventricular Hemorrhage (IVH) in Extremely Premature NeonatesRoberts JC, Lundy M, Zwilling R, Burns R, Wang H, Tarantino M, J Thromb Haemost, 1/1/2016
- A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function.Roberts JC, Christopherson PA, Morateck PA, Yan K, Hoffmann RG, Gill JC, Montgomery RR, The Zimmerman Program Investigators, Blood, 1/14/2014
- Join now to see all
Lectures
- An ELISA-Based VWF Functional Screening Assay for Discriminating the Phenotypic Variants of VWDMontreal, Canada - 1/10/2017
- Hemophilia Clinical and Cost Optimization for Managed Care and Specialty Pharmacy: Cost Optimization Strategies for Factor Replacement Therapy1/29/2016
- Characterization of Laboratory Coagulation Parameters and Risk Factors for Intraventricular Hemorrhage (IVH) in Extremely Premature NeonatesMontpellier, France - 1/25/2016
- Join now to see all
Other
- Goal Attainment Scaling (Goal-Hem) Hemophilia Treatment Center Training/Demonstration VideoRoberts JC
https://vimeo.com/230431423/
1/21/2017 - Current and Emerging Treatment Options for Hemophilia A: A Clinician’s ReviewJonathan C. Roberts, MD, CME/ABIM MOC Medscape Education Oncology/National Hemophilia Foundation
https://www.medscape.org/viewarticle/884939
1/8/2017 - Helping Ensure A Bright Future for HematologyRoberts JC, Featured Interview for HEMAWARE The Bleeding Disorders Magazine, National Hemophilia Foundation, Sum
1/1/2017 - Join now to see all
Press Mentions
Treating Von Willebrand Disease: Does the Type Matter?November 16th, 2022- Hemophilia: There’s a New App for ThatMarch 16th, 2022
Outbreak of Synthetic Cannabinoid–Associated Bleeding Disorders in IllinoisSeptember 27th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
